ACP-196
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for ACP-196, covering 2019-03-26 to 2020-07-29. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM) [Phase 1, Phase 2]